Clinical Significance of the Head-Up Tilt Test in Improving Prognosis in Patients with Possible Neurally Mediated Syncope.

atrial fibrillation atrioventricular block hypotension sinoatrial node tilt-table test vasovagal syncope

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
15 Sep 2021
Historique:
received: 06 08 2021
revised: 03 09 2021
accepted: 08 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Syncope is commonly encountered in daily clinical practice. Depending on its etiology (benign or life-threatening conditions or environmental triggers), syncope can be neurally mediated (reflex), cardiac, or orthostatic. Furthermore, neurologic disease can cause symptoms that mimic syncope. However, there is limited research on neurally mediated syncope (NMS), which is considered a benign disorder, and close follow-ups are rarely performed. NMS can cause serious clinical events, including severe trauma and car accidents. The head-up tilt test (HUTT) is the gold standard for diagnosing NMS; however, its clinical significance remains unknown, and its relevance to NMS prognosis requires further research. This retrospective study aimed to assess the clinical significance of the HUTT for NMS. We reviewed the charts of 101 patients who underwent HUTT at Tokai University Hospital in Japan between January 2016 and March 2019. During the HUTT, 72 patients (69.2%) experienced syncope. Patients were followed up for 886.1 ± 457.7 days (interquartile range: 518-1293 days). The syncope recurrence rate was 16.9%; however, no significant difference was observed between the two groups (HUTT positive vs. negative) (13.8% vs. 18.1%,

Identifiants

pubmed: 34571796
pii: biology10090919
doi: 10.3390/biology10090919
pmc: PMC8493797
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 20K08498
Organisme : Japan Society for the Promotion of Science
ID : 21K16037

Références

Minerva Cardioangiol. 2000 Mar;48(3):69-78
pubmed: 10838836
Circ Arrhythm Electrophysiol. 2010 Apr;3(2):141-7
pubmed: 20160169
Circulation. 2013 Mar 26;127(12):1330-9
pubmed: 23529534
Circulation. 1999 Oct 26;100(17):1798-801
pubmed: 10534467
Yonsei Med J. 2010 Jul;51(4):499-503
pubmed: 20499413
Europace. 2004 May;6(3):199-204
pubmed: 15121070
J Am Coll Cardiol. 2017 Aug 1;70(5):e39-e110
pubmed: 28286221
PLoS One. 2019 Apr 18;14(4):e0214733
pubmed: 30998713
PLoS One. 2021 Jun 25;16(6):e0251450
pubmed: 34170907
Arch Cardiovasc Dis. 2019 Feb;112(2):82-94
pubmed: 30600217
JAMA. 2001 Jan 3;285(1):52-9
pubmed: 11150109
J Am Coll Cardiol. 2005 Feb 15;45(4):484-8
pubmed: 15708690
J Am Geriatr Soc. 2019 Oct;67(10):2023-2030
pubmed: 31339174
J Am Coll Cardiol. 2003 Aug 6;42(3):495-501
pubmed: 12906979
Eur Heart J. 2018 Jun 1;39(21):e43-e80
pubmed: 29562291
Am J Cardiol. 1990 Jun 1;65(20):1322-7
pubmed: 1971497
Age Ageing. 2011 Nov;40(6):696-702
pubmed: 21908471
Adolesc Med. 2001 Feb;12(1):105-32
pubmed: 11224026
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Eur Heart J. 2009 Nov;30(21):2631-71
pubmed: 19713422
Ann Emerg Med. 2011 Sep;58(3):250-6
pubmed: 21288597
Eur J Prev Cardiol. 2016 Jun;23(9):1003-10
pubmed: 26268263
PLoS One. 2015 Apr 10;10(4):e0120788
pubmed: 25860977
Eur J Prev Cardiol. 2016 Aug;23(12):1261-72
pubmed: 26864396
Expert Rev Med Devices. 2019 Jan;16(1):45-55
pubmed: 30522350
N Engl J Med. 2002 Sep 19;347(12):878-85
pubmed: 12239256
J Electrocardiol. 2018 Jul - Aug;51(4):583-587
pubmed: 29996994
Curr Opin Cardiol. 1996 Jan;11(1):32-41
pubmed: 8664530
Europace. 2000 Jan;2(1):66-76
pubmed: 11225598
JACC Clin Electrophysiol. 2018 Nov;4(11):1383-1396
pubmed: 30466842
Neurologist. 2002 May;8(3):175-85
pubmed: 12803689

Auteurs

Kengo Ayabe (K)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Tomoyoshi Komiyama (T)

Department of Clinical Pharmacology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Misaki Hasegawa (M)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Tetsuri Sakai (T)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Masahiro Morise (M)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Susumu Sakama (S)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Atsuhiko Yagishita (A)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Mari Amino (M)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Yuji Ikari (Y)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Koichiro Yoshioka (K)

Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Kanagawa, Japan.

Classifications MeSH